Related Experiment Video

Updated: Mar 21, 2026

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.5K

Targeting the Human Epidermal Growth Factor Receptors with Immuno-PET: Imaging Biomarkers from Bench to Bedside

Gabriela Kramer-Marek1, Wim J G Oyen2

  • 1Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; and gabriela.kramer-marek@icr.ac.uk.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|May 14, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

2.0K
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

836

Related Experiment Videos

Last Updated: Mar 21, 2026

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.5K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

2.0K
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

836

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K

Articles linked to this work by shared authors, journal, and citation graph.

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.

Diagnostics (Basel, Switzerland)·2026

18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.

JAMA oncology·2026

PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

[18F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study).

BMC cancer·2025

Four-dimensional Computed Tomography Imaging in Primary Hyperparathyroidism: Multireader Multicase Study of Both Neuroradiologists and General Radiologists of Imaging Approaches With Less Phases.

Journal of computer assisted tomography·2025

How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.

Cancer treatment reviews·2025

β-Cell Mass and Function, Pancreatic Volume, and Fat Differences Between Short- and Long-Duration Type 1 Diabetes: A Detailed PET/CT Imaging Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

[68Ga]Ga-SSO120 PET/CT Imaging in Pediatric Patients with Neuroblastoma: Biodistribution and Whole-Body Radiation Dosimetry.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Preclinical Evaluation on the Radiohybrid Tandem [18F]La- and [225Ac]Ac-rhPSMA-10.1 for Targeted α-Therapy of Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Value of Dual-Time-Point [18F]Fluorocholine PET/CT for Challenging Preoperative Parathyroid Imaging.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

[89Zr]Zr-DFO-EPO Imaging of Ischemia-Induced Cellular Stress.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

68Ga-Labeled Dimeric Cyclic Peptide for Nectin-4-Targeted PET Imaging: From Preclinical Evaluation to First-in-Human Imaging in Breast Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Multiple-Session Magnetic Fluid Hyperthermia: Augmented MNPs Penetration Led to Complete Eradication of Hetero-Multicellular Breast Tumor Spheroids via Apoptosis.

ACS applied bio materials·2026

Canadian Cardiovascular Society/Canadian Society of Cardiovascular Surgery/Canadian Association of Interventional Cardiology Clinical Practice Update on Transcatheter Mitral and Tricuspid Valve Intervention: Patient Evaluation and Management.

The Canadian journal of cardiology·2026

MicroRNA Therapeutics in Cancer: Revisiting the Promise and Understanding the Limitations of Clinical Translation.

Current gene therapy·2026

Prognostic Impact of a Simple GDMT Score on Clinical Outcomes and Cardiac Reverse Remodelling in Patients with ADHF: Insights from the JROADHF-Next Registry.

CJC open·2026

Persistent Therapeutic Burden after Device-Aided Therapy in Parkinson's Disease: Insights from Post-DAT MANAGE-PD Assessment.

Movement disorders clinical practice·2026

Limiting Trial-and-Error: Linker-Based 2D Descriptor Analysis to Support Very Early Proteolysis-Targeting Chimeras Design.

ChemMedChem·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us